Sara Olson, PhD

Associate Attending Epidemiologist

Sara Olson, PhD

Associate Attending Epidemiologist

Office Phone

646-888-8305

E-mail

olsons@mskcc.org

Current Research Interests

Dr. Olson’s interests are in environmental and genetic risk factors for cancer, particularly endometrial and pancreatic cancers and glioma.  Dr. Olson is a founder and leader of the Epidemiology of Endometrial Cancer Consortium (E2C2). This NCI-supported consortium includes investigators from the US and other countries who are interested in combining resources in order to study this underfunded disease.  Dr. Olson’s completed population-based study of Estrogen, Diet, Genetics and Endometrial Cancer is a contributor to E2C2 analyses.  Among the ongoing analyses in E2C2, Dr. Olson and colleagues are pooling data from several studies to determine risk factors in African American women.  Incidence in this minority group is lower than for white women, but mortality is considerably worse.  A recent analysis of SEER-Medicare data addressed the question of whether diabetes and other comorbid conditions accounted in part for this disparity. The poorer survival in black women persisted after consideration of other medical conditions.  The pancreatic cancer epidemiology study is part of the Familial Pancreatic Cancer Registry study led by Robert Kurtz, MD, which includes surveillance of unaffected relatives of pancreatic cancer cases. Dr. Olson is pursuing her interests in the association of allergies with both risk and outcomes, including a pooled analysis of allergies and risk in several studies in the Pancreatic Cancer Case-Control Consortium (PanC4), a prospective study of IgE, a marker of allergies, and risk, and a pilot study of IgE and survival.  Other activities within PanC4 include pathway analyses of data from the recent genome wide association studies focused on genes involved in allergies.  Dr. Olson is also a member of the PanC4 Steering committee.  In glioma, MSKCC is a contributor to the GLIOGENE consortium, which studies the familial risk of glioma, and to the Glioma International Case-Control Study.

Education

Columbia University

Publications

Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E. Zauber AG, Kurtz RC. Allergies, variants in IL-4 and IL-4Rá genes, and risk of pancreatic cancer. Cancer Detection Prev 2007; 31:345-51.

Olson SH, Orlow I, Bayuga S, Sima C, Bandera EV, Pulick K, Faulkner S, Tommasi D, Egan D, Roy P, Wilcox H, Asya A, Modica I, Asad H, Soslow R, Zauber AG. Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control, 2008:19:955-63.

Setiawan VW, Doherty JA, Shu X, Akbari MR, Chen C, De Vivo I, DeMichele A, Garcia-Closas M, Goodman MT, Haiman CA, Hankinson SE, Henderson BE, Horn-Ross PL, Lacey JV, Jr., Le Marchand L, Levine DA, Liang X, Lissowska J, Lurie G, McGrath M, Narod SA, Rebbeck TR, Ursin G, Weiss NS, Xiang Y-B, Yang HP, Zheng W, Olson SH. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: A pooled analysis in E2C2. Cancer Epidemiol Biomarkers Prev, 2009;18:242-7.

Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick KE, Faulkner S, Zauber AG, Olson SH. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev, 2009;18:1448-56.

Olson SH, Chou J, Ludwig E, O’Reilly E, Allen PJ, Jarnagin WR, Bayuga S, Simon J, Gonen M, Reisacher WR, Kurtz RC. Allergies, obesity, other risk factors, and survival from pancreatic cancer. Intl J Cancer, in press

Read more

  1. Olson SH, Kelsey JL, Pearson TA, Levin B. Evaluation of random-digit dialing as a method of control selection in case-control studies. Am J Epidemiol 1992; 135:210-22. [PubMed Abstract]

  2. Olson SH, Kelsey JL, Pearson TA, Levin B. Characteristics of a hypothetical group of hospital controls for a case-control study. Am J Epidemiol 1994; 139:302-11. [PubMed Abstract]

  3. Olson SH, Trevisan M, Marshall JR, Graham S, Zielezny M, Vena JE, Hellmann R, Freudenheim JL. Body mass index, weight gain and risk of endometrial cancer. Nutr Cancer 1995; 23:141-9. [PubMed Abstract]

  4. Wilt S, Olson SH. Prevalence of domestic violence in the United States. J Am Med Womens Assoc 1996; 51:77-82. [PubMed Abstract]

  5. Olson SH, Vena JE, Dorn JP, Marshall JR, Zielezny M, Laughlin R, Graham S. Exercise, occupational activity and risk of endometrial cancer. Ann Epidemiol 1997; 7:46-53. [PubMed Abstract]

  6. Olson SH, Finstad CL, Harlap S, Kurian L, Saigo PE, Barakat RR. A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer. Cancer Epidemiol Biomarkers Prev 1997;6:815-7. [PubMed Abstract]

  7. Olson SH, Zauber A, Tang J, Harlap S. Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology 1998;9:669-71. [PubMed Abstract]

  8. Olson SH, Mignone L, Harlap S. Selection of control groups using a commercial database and random digit dialing. Am J Epidemiol 2000;152:585-92. [PubMed Abstract]

  9. Fleischauer AT, Olson SH, Mignone L, Simonsen N, Caputo TA, Harlap S. Dietary antioxidants, supplements, and risk of epithelial ovarian cancer. Nutr Cancer. 2001;40:92-8. [PubMed Abstract]

  10. Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer in cases and controls. Obstet Gynecol 2001;98:212-7. [PubMed Abstract]

  11. Olson SH. Reported participation in case-control studies: changes over time. Am J Epidemiol 2001; 154:574-81. [PubMed Abstract]

  12. Harlap S, Olson SH, Akhmedkhanov A, Barakat RR, Caputo T, Sanchez D, Xue X. Epithelial ovarian cancer and European birthplace of grandparents. Gynecol Oncol 2001;81:25-32. [PubMed Abstract]

  13. Harlap S, Olson SH, Barakat RR, Caputo T, Formenti S, Jacobs AJ, Nakraseive C, Xue X. Diagnostic X-rays and risk of epithelial ovarian carcinoma in Jews. Ann Epidemiol 2002;12:426-34. [PubMed Abstract]

  14. Olson SH, Voigt LF, Begg CB, Weiss NS. Reporting participation in case-control studies [Commentary]. Epidemiology 2002;13:123-6. [PubMed Abstract]

  15. Harlap S, Olson SH, Curtin JP, Caputo TA, Nakraseive C, Sanchez D, Xue X. Epithelial ovarian carcinoma and fertility of parents. Epidemiology 2002;13:59-65. [PubMed Abstract]

  16. Stellman SD, Chen Y, Muscat JE, Djordjevic MV, Richie JP, Lazarus P, Thompson S, Altorki N, Berwick M, Citron ML, Harlap S, Kaur T, Neugut AI, Olson SH, Travaline JM, Witorsch P, Zhang Z-F. Lung cancer risk in white and black Americans. Ann Epidemiol 2003; 13:294-302. [PubMed Abstract]

  17. Muscat JE, Chen S-Q, Richie JP, Altorki NK, Citron M, Olson SH, Neugut AI, Stellman SD. Risk of lung cancer among users of nonsteroidal anti-inflammatory drugs. Cancer 2003; 97:1732-6. [PubMed Abstract]

  18. Bandera EV, Kushi LH, Olson SH, Chen WY, Muti P. Alcohol consumption and endometrial cancer: some unresolved issues. Nutr Cancer 2003; 45:24-9. [PubMed Abstract]

  19. Olson SH, Carlson MDA, Ostrer H, Harlap S, Stone A, Winters M, Ambrosone CB. Genetic variants in SOD2, MPO, and NQO1 and risk of ovarian cancer. Gynecol Oncol 2004; 93:615-2. [PubMed Abstract]

  20. Brooks DR, Austin JHM, Heelan R, Ginsberg M, Shin V, Olson SH, Muscat JE, Stellman SD. Influence of type of cigarette on peripheral versus central lung cancer. Cancer Epidemiol Biomarker Prev 2005;14: 576-581. [PubMed Abstract]

  21. Olson SH, Iyer S, Scott J, Erez O, Samuel S, Markovits T, Schwartz M, Toro C, Lau N, Gambarin-Gelwan M, Kurtz RC. Cancer history and other personal factors affect quality of life in patients with hepatitis C. Health Qual Life Outcomes 2005; 3:39. [PubMed Abstract]

  22. Sato E, Olson SH, Ahn J, Jungbluth A, Frosina D, Bundy B, Qian F, Gnjatic S, Ambrosone C, Kepner J, Keitz B, Odunsi T, Ritter G, Lele S, Chen Y-T, Ohtani H, Old LJ, Odunsi K. Intra-epithelial CD8+ tumor infiltrating lymphocytes and CD8+/CD4+ T-cell ratio are associated with favorable prognosis in epithelial ovarian cancer. PNAS 2005; 102:18538-43. [PubMed Abstract]

  23. Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer. A HuGE Review. Amer J Epidemiol 2007; 165:235-45. [PubMed Abstract]

  24. Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E, Zauber AG, Kurtz RC. Allergies, variants in IL-4 and IL-4Rα genes, and risk of pancreatic cancer. Cancer Detection Prev 2007; 31:345-51. [PubMed Abstract]

  25. Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E, Davis F, Houlston R, Il’yasova D, Jenkins R, Johansen C, Lai R, Lau C, McCarthy B, Nielsen H, Olson SH, Sadetzki S, Shete S, Wiklund F, Wrensch M, Yang P, Bondy M. GLIOGENE—An international consortium to understand familial glioma. Cancer Epidemiol Biomarker Prev 2007; 16:1730-4. [PubMed Abstract]

  26. House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gonen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 2008; 12:270-8. [PubMed Abstract]

  27. Olson SH, Orlow I, Bayuga S, Sima C, Bandera EV, Pulick K, Faulkner S, Tommasi D, Egan D, Roy P, Wilcox H, Asya A, Modica I, Asad H, Soslow R, Zauber AG. Variants in hormone biosynthesis genes and risk of endometrial cancer.  Cancer Causes Control 2008; 19:955-63. [PubMed Abstract]

  28. Olson SH, Chen C, De Vivo I, Doherty JA, Hartmuller V, Horn-Ross PL, Lacey JV Jr., Lynch SM, Sansbury, L, Setiawan VW, Schouten LJ, Shu XO. Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium. Cancer Causes Control 2009; 20:491-6. [PubMed Abstract]

  29. Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, DeMichele A, Goodman MT, Haiman CA, Henderson BE, Horn-Ross P, Le Marchand L, Levine DA, Liang X, Lurie G, McGrath M, Narod SA, Rebbeck TR, Ursin G, Weiss NS, Xiang Y-B, Zheng W, Olson SH. Two Estrogen-related variants in CYP19A1 and endometrial cancer risk: pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Epidemiol Biomarkers Prev 2009; 18:242-7. [PubMed Abstract]

  30. Bandera EV, Williams MG, Sima C, Bayuga S, Pulick KE, Wilcox H, Soslow R, Zauber AG, Olson SH. Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 2009; 20:1117-27. [PubMed Abstract]

  31. Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick KE, Faulkner S, Zauber AG, Olson SH. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev 2009; 18:1448-56. [PubMed Abstract]

  32. Duffy A, Capanu M, Allen P, Kurtz R, Olson SH, Ludwig E, Klimstra DS. O’Reilly EM. Pancreatic adenocarcinoma in a young patient population—12-year experience at Memorial Sloan Kettering Cancer Center. J Surg Oncol 2009; 100:8-12. [PubMed Abstract]

  33. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW Jr, Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009 Sep; 41(9):986-90. Epub 2009 Aug 2. [PubMed Abstract]

  34. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson M, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet W, Berg CD, Boutron-Rualt M-C, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Overvad K, Parikh H, Patel AV, Peeters PHM, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu X-O, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF, Jr., Hoover RN, Hartge P, Chanock SJ. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010 Mar; 42(3):224-8. [PubMed Abstract]

  35. Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Yang P, Rynearson AL, Wrensch M, McCoy L, Wienkce JK, McCarthy B, Davis F, Vick NA, Johansen C, Bødtcher H, Sadetzki S, Bruchim RB, Yechezkel GH, Andersson U, Melin BS, Bondy ML, Houlston RS. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. Fam Cancer 2010 Sep; 9(3):413-21. [PubMed Abstract]

  36. Bandera EV, Williams-King MG, Sima C, Bayuga-Miller S, Pulick K, Wilcox H, Zauber AG, Olson SH. Coffee and tea consumption and endometrial cancer risk in a population-based study in New Jersey. Cancer Causes Control 2010 Sep; 21(9):1467-73. [PubMed Abstract]

  37. Olson SH, Chou JF, Ludwig E, O’Reilly E, Allen PJ, Jarnagin WR, Bayuga S, Simon J, Gonen M, Reisacher WR, Kurtz RC. Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 2010 Nov 15; 127(10):2412-9. [PubMed Abstract]

  38. Scheurer ME, Etzel CJ, Liu M, Barnholtz-Sloan J, Wiklund F, Tavelin B, Wrensch MR, Melin BS, Bondy ML; GLIOGENE Consortium. Familial aggregation of glioma: a pooled analysis. Am J Epidemiol 2010 Nov 15; 172(10):1099-107. [PubMed Abstract]

  39. Chandran U, Bandera EV, Williams-King MG, Sima C, Bayuga S, Pulick K, Wilcox H, Zauber AG, Olson SH. Adherence to the dietary guidelines for Americans and endometrial cancer risk. Cancer Causes Control 2010 Nov; 21(11):1895-904. [PubMed Abstract]

  40. Ludwig E, Olson SH, Bayuga S, Simon JA, Schattner MA, Gerdes H, Allen PJ, Jarnagin WR, Kurtz RC. Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol 2011 May;106(5):946-54. [PubMed Abstract]

  41. Bertuccio P, La Vecchia C, Silverman D, Petersen G, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Lucenteforte E, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Bosetti C, Boffetta P. Cigar and pipe  smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4), Annals of Oncology 2011 Jan 18. Annals of Oncology 2011 Jun;22(6):1420-6. [PubMed Abstract]

  42. Olson SH, Layne T, Simon JA, O’Reilly E, Allen PJ, Kurtz RC. Studying cancer in minorities: a look at the numbers. Cancer 2011 June 15;117(12):2762-9. [PubMed Abstract]

  43. Chandran U, Bandera EV, Williams-King MG, Paddock L, Rodriguez-Rodriguez L, Lu S-E, Faulkner S, Pulick K, Olson SH. Healthy eating index and ovarian cancer risk. Cancer Causes Control 2011 Apr;22:563-71. [PubMed Abstract]

  44. Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O’Mara T, Olson SH, Narod SA, Matsuno RK, Lissowska J, Levine DA, Le Marchand L, Kolonel LN, Henderson BE, Garcia-Closas M, Doherty JA, De Vivo I, Chen C, Brinton L, Akbari MR, Australian National Endometrial Cancer Study Group, Goodman MT on behalf of the Epidemiology of Endometrial Cancer Consortium (E2C2). The obesity-associated polymorphisms FTO rs9939609n and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS ONE 2011 Feb 8;6(2):e16756. [PubMed Abstract]

  45. Stadler ZK, Salo-Mullen E, Sabbaghian N, Simon JA, Zhang L, Olson SH, Kurtz R, Offit K, Foulkes WD, Robson ME, Tischkowitz M. Germline PALB2 mutation analysis in breast-pancreas cancer families. J Med Genet 2011 March 17. [PubMed Abstract]

  46. Olson SH. Selected medical conditions and risk of pancreatic cancer. Mol Carcinog 2012 Jan; 51(1):75-97. [PubMed Abstract]

  47. Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, Li J, Michailidou K, Lu Y, Rider DN, Palmieri RT, Stutz MD, Lambrechts D, Despierre E, Lambrechts S, Vergote I, Chang-Claude J, Nickels S, Vrieling A, Flesch-Janys D, Wang-Gohrke S, Eilber U, Bogdanova N, Antonenkova N, Dürst M, Dörk T, Goodman MT, Lurie G, Wilkens LR, Matsuno RK, Kiemeney LA, Aben KKH, Marees T, Massuger LFAG, Fridley BL, Vierkant RA, Bandera EV, Olson SH, Orlow I, Rodriguez-Rodriguez L, Cook LS, Le ND, Brooks-Wilson A, Kelemen LE, Campbell I, Gayther SA, Ramus SJ, Gentry-Maharaj A, Menon U,  Ahmed S, Baynes C, Pharoah PD, Muir K, Lophatananon A, Chaiwerawattana A, Wiangnon S, Macgregor S, Easton DF, Reddel RR, Goode EL, Chenevix-Trench G. Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One 2011 6(9): e24987. [PubMed Abstract]

  48. Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Yang P, Vick NA, Wrensch M, Davis FG, McCarthy BJ, Leung EH, Davis C, Cheng R, Hosking FJ, Armstrong GN, Liu Y, Yu RK, Henriksson R, The Gliogene Consortium, Melin BS, Bondy ML. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res 2011 Dec 15; 71(24):7568-7575. [PubMed Abstract]

  49. Mukherjee S, Simon S, Bayuga S, Ludwig E, Viale A, Kurtz RC, Olson SH, Klein RJ. Including additional controls from public databases improves the power of a genome-wide association study. Hum Hered 2011 72(1):21-34. [PubMed Abstract]

  50. Bandera EV, King M, Chandran U, Paddock LE, Rodriguez-Rodriguez L, Olson SH. Phytoestrogen consumption from food and supplements and epithelial ovarian cancer risk: a population-based case-control study.  BMC Women’s Health 2011, 11:40. [PubMed Abstract] 

  51. Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji B-T, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao Y-T, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C. Cigarette smoking and pancreatic cancer: an analysis from the international Pancreatic Cancer Case-Control Consortium (PanC4).  Ann Oncol 2012;23:1880-8. [PubMed Abstract]

  52. Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, Brown CL, Elkin EB.  The impact of race and comorbidity on survival in endometrial cancer.  Cancer Epidemiol Biomarkers Prev 2012; 21:753-760. [PubMed Abstract]

  53. Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey Jr. JV, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu X, Spurdle AB, Strom BL, The Australian National Endometrial Cancer Study Group, Thompson PJ, Ursin G, Webb PM, Weiss N, Wentzensen N, Xiang Y, Yang HP, Yu H, Horn-Ross PL and  De Vivo I. Age at last birth in relation to risk of endometrial cancer: Pooled analysis in the Epidemiology of Endometrial Cancer Consortium.  Amer J Epidemiol 2012; 176(4):269-78. [PubMed Abstract]

  54. Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Mandelson MT, Petersen G, Zheng W, Agalliu I, Albanes D, Boutron-Ruault M, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw K, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Shu X, Tjønneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Watters J, Yu H, Zeleniuch-Jacquotte A, Amundadottir L, Stolzenberg-Solomon RZ. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis 2012;33:1384-90. [PubMed Abstract]

  55. Willis JA, Olson SH, Orlow I, Mukherjee S, McWilliams RR, Kurtz RC, Klein RJ. A replication study and genome-wide scan of single nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Res 2012;18:3942-51. [PubMed Abstract]

  56. Gifkins D, Olson SH, Demissie K, Lu S-E, Bandera EV.  Total and individual antioxidant intake and endometrial cancer risk: results from a population-based case-control study in New Jersey.  Cancer Causes Control 2012;23:887-95. [PubMed Abstract]

  57. Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen GM, La Vecchia C, Boffetta P. Pancreatitis and pancreas cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Annals of Oncol 2012;23:2964-70. [PubMed Abstract]

  58. Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau C, Scheurer ME, Armstrong GN, Houlston RS,  Hosking FJ, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, LaChance D, Vick NA, Wrensch M, Davis F, McCarthy BJ, Andersson U, Chanock S, The Gliogene Consortium, Bondy ML. Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Human Genet 2012;131:1507-17. [PubMed Abstract]

  59. Cote ML, Atikukke G, Ruterbusch JJ, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley Alford S, Elshaikh MA, Gaba AR, Schultz D, Haddad R, Munkarah AR, Ali-Fehmi R.  Racial differences in oncogene mutations detected in early stage, low grade endometrial cancers.  Int J Gyn Cancer 2012; 22:1367-72. [PubMed Abstract]

  60. Gifkins D, Olson SH, Paddock L, King M, Demissie K, Lu S, Kong AT, Rodriguez-Rodriguez L, Bandera EV.  Total and individual antioxidant intake and risk of epithelial ovarian cancer. BMC Cancer 2012;Jun 1. [PubMed Abstract]

  61. Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Mandelson MT, Petersen G, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Shu XO, Tjønneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Watters J, Yu H, Zeleniuch-Jacquotte A, Amundadottir L, Stolzenberg-Solomon RZ. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis 2012; 33(7):1384-90. [PubMed Abstract]

  62. Sun X, Vengochea J, Elston R, Chen Y, Amos C, Armstrong G, Bernstein JL, Claus E, Davis F, Houlston RS, Il’yasova D, Jenkins RB, Johansen C, Lai R, Lau CC, Liu Y, McCarthy BJ, Olson SH, Sadetzki S, Schildkraut J, Shete S, Vick NA, Wrensch M, Yang P, The Gliogene Consortium, Melin B, Bondy ML,  Barnholtz-Sloan J. A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma. Cancer Epidemiol Biomarkers Prev 2012; 21:2242-51. [PubMed Abstract]

  63. Cook LS, Nelson HE, Cockburn M, Olson SH, Muller CY, Wiggins CL.  Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites.  Cancer Causes Control 2013; 24:61-69. [PubMed Abstract]

  64. Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB, Barnholtz-Sloan JS, Ilyasova D, Schildkraut J, Johansen C, Houlston RS, Shete S, Amos CI, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA, Merrell R, Wrensch M, Davis FG, McCarthy BJ, Lai R, The Gliogene Consortium, Melin BS, Bondy ML.  Description of selected characteristics of familial glioma patients. Eur J Cancer 2013 Jan 4. [PubMed Abstract]

  65. Lu Y, Chen X, Beesley J, Johnatty SE, Defazio A; Australian Ovarian Cancer Study (AOCS) Study Group, Lambrechts S, Lambrechts D, Despierre E, Vergotes I, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Dörk T, Dürst M, Antonenkova N, Bogdanova N, Goodman MT, Lurie G, Wilkens LR, Carney ME, Butzow R, Nevanlinna H, Heikkinen T, Leminen A, Kiemeney LA, Massuger LF, van Altena AM, Aben KK, Kjaer SK, Høgdall E, Jensen A, Brooks-Wilson A, Le N, Cook L, Earp M, Kelemen L, Easton D, Pharoah P, Song H, Tyrer J, Ramus S, Menon U, Gentry-Maharaj A, Gayther SA, Bandera EV, Olson SH, Orlow I, Rodriguez-Rodriguez L, Macgregor S, Chenevix-Trench G. Genome-wide association study for ovarian cancer susceptibility using pooled DNA. Twin Res Hum Genet 2012 Oct; 15(5):615-23. [PubMed Abstract]

  66. Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, Kooperberg C, Lacroix A, Li D, Mandelson MT, Olson SH, Petersen G, Risch HA, Yu K, Wolpin BM, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovanucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman-Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Tjønneland A, Trichopoulos D, Virtamo J, Visvanathan K, Elena JW, Yu H, Zeleniuch-Jacquotte A, Stolzenberg-Solomon RZ. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control. 2013; 24(3):595-602. [PubMed Abstract]

My Projects